Rocket Lab Is Playing a Much Bigger Game Than Rocket Launches, Eyes 90% Upside
Rocket Lab (RKLB) reported record Q2 revenue of $234.07 million, up 62% YoY, with a $2.36 billion backlog. The company is expanding beyond launches, targeting $870M in annual revenue from the pending Iridium deal. 24/7 Wall St. set a $120.88 price target, implying 90% upside, citing growth opportunities and risks like Neutron delays and integration challenges.
How this was made

The 30-second read
Why it matters
The earnings beat and strategic deals provide a catalyst for a re‑rating, but execution risk tempers the upside.
Market read
Rocket Lab's earnings and acquisition news could drive significant price movement and influence the broader space‑tech sector.
What to watch
Potential dilution from $1.53B ATM proceeds and the timing uncertainty of the Iridium acquisition.
Background
Rocket Lab is transitioning from a pure launch provider to an end‑to‑end space‑services company, leveraging its Iridium acquisition and defense contracts.
Ticker impact
Rocket Lab reported Q2 FY26 revenue of $234.07M, a 62% YoY increase, and disclosed a pending Iridium acquisition that could add $870M annual revenue.
Potential upside of ~90% if Iridium deal closes and Neutron launch stays on schedule.
The combination of record revenue, a sizable backlog, and a strategic acquisition provides a clear catalyst for a re-rating.
Market effects
Highlights growing consolidation in the small‑launch and satellite services sector, pressuring peers to pursue similar vertical integration.
U.S. space‑tech stocks may see increased investor interest as Rocket Lab's strategy gains traction.
The Iridium deal underscores the strategic importance of satellite communications worldwide.
Counterpoint
Execution risk remains high; integration challenges and continued net losses could delay upside.
Key entities
- companyRocket Lab
U.S. listed space launch and services provider (NASDAQ:RKLB).



